Biophysical Therapeutics, Inc.

Drug to Slow Aging?

Print
Claim My Business
Security Type
CAFES
Categories
Healthcare & Medical, Education
Min Investment
$100
Location
Wilmington, DE
Expected Close Date
August 28, 2024
Target Raise
$50.00K-$124.00K
No. Investors
129
Security Price
$1
Number of Employees
1
Cash
$90
Revenue
$0
Short Term Debt
$0
Cost of Goods
$0
Long Term Debt
$0
Net Income
$0

Key Deal Facts

Have patented drug that slows metabolic rate. Slowing metabolic rate slows aging.
Professor George Church (of Harvard Medical School) is Advisor.
Reinforced Ventures is an investor.
Everyone ages and no one wants to.
A drug for aging revolutionizes cosmetics.
And medicine (many diseases are caused by aging).

Management Team / Advisory Board Bios

Dr. Michael Forrest Drug Inventor | CEOCambridge University biochemistry graduate | Ph.D. computer science | computational biology expert | drug inventor.
Amount Raised : $137,270
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments